A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
about
A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
description
im Dezember 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2018
@uk
name
A comparative pharmacokinetic ...... cy in preclinical tumor models
@en
A comparative pharmacokinetic ...... cy in preclinical tumor models
@nl
type
label
A comparative pharmacokinetic ...... cy in preclinical tumor models
@en
A comparative pharmacokinetic ...... cy in preclinical tumor models
@nl
prefLabel
A comparative pharmacokinetic ...... cy in preclinical tumor models
@en
A comparative pharmacokinetic ...... cy in preclinical tumor models
@nl
P2093
P356
P1433
P1476
A comparative pharmacokinetic ...... cy in preclinical tumor models
@en
P2093
Aparajitha Vaidyanathan
Grace Poon
Jeffrey Hanke
Kaiming Sun
Keith Mikule
Sridhar Ramaswamy
Zebin Wang
Zhi-Yi Zhang
P304
37080-37096
P356
10.18632/ONCOTARGET.26354
P407
P577
2018-12-14T00:00:00Z